Annual report pursuant to Section 13 and 15(d)

Stock Incentive Plan (Details Narrative)

v3.22.1
Stock Incentive Plan (Details Narrative) - USD ($)
 12 Months Ended 69 Months Ended
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Oct. 31, 2017
Apr. 30, 2016
Stock option expiry   10 years        
Stock options outstanding   $ 1,800,000   $ 1,800,000    
Weighted-average exercise price   $ 4.78   $ 4.78    
Unamortized unvested balance of stock base compensation   $ 2,500,000   $ 2,500,000    
Unamortized unvested balance of stock base compensation, period   2 years 7 months 6 days        
Unvested restricted stock units, granted   124,374        
Weighted average exercise price of unvested expected to vest share   $ 7.28   $ 7.28    
Description of exercise price   exercise prices ranging from $4.01 to $9.67 per share which vest over 1 to 4 years        
Weighted average vested exercise price   $ 4.06   $ 4.06    
Aggregate stock option purchase of shares   403,476        
Research and Development Expenses            
Employee and non-employee director stock-based compensation expense   $ 866,537 $ 636,867      
Minimum Member            
Risk free interest rate       0.40%    
Expected term       4 years 8 months 12 days    
Volatility       55.00%    
Maximum Member            
Risk free interest rate       2.90%    
Expected term       6 years 2 months 12 days    
Volatility       85.00%    
Stock award pool [Member]            
Share based compensation arrangement by share based payment award number of additional shares authorized 1,500,000          
2016 Stock Incentive Plan            
Share based compensation arrangement by share based payment award number of shares authorized           700,000
Stock option grants term period   10 years        
2016 Stock Incentive Plan | Minimum Member            
Exercise Price   $ 4.01   $ 4.01    
2016 Stock Incentive Plan | Maximum Member            
Exercise Price   $ 9.67   $ 9.67    
October 2017 | Board of Directors            
Share based compensation arrangement by share based payment award number of shares authorized         1,600,000  
April 2020 | Board of Directors            
Share based compensation arrangement by share based payment award number of shares authorized 3,100,000          
Vested 6/48ths on 6 month anniversary of grant date and 1/48th per month thereafter            
Option to purchase shares   375,704        
Vested quarterly over one year            
Option to purchase shares   17,772        
Vested monthly over one year            
Option to purchase shares   10,000        
Options [Member]            
Stock Option Granted   403,476        
Research and Development Expense [Member]            
Stock-based compensation expense for non-employees   $ 41,200 70,252      
Employee and non-employee director stock-based compensation expense   $ 560,317 $ 613,771